Related Experiment Video
Updated: Jun 27, 2026
07:19
Bacteriophage Removal from Infected Salmonella Cultures
Published on: June 28, 2024
Protecting Newborns from Multidrug-Resistant Infections: The Emerging Role of Bacteriophages
Olaf Bajrak1, Andrzej Górski1,2,3, Ewa Jończyk-Matysiak1
1Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), 53-114 Wrocław, Poland.
Viruses
|June 26, 2026
Summary
Newborn bacterial infections from resistant pathogens need new treatments. Bacteriophage therapy offers a promising alternative, but more research is needed, especially regarding newborns and ethical considerations.
Area of Science:
- Microbiology
- Infectious Diseases
- Virology
Background:
- Neonatal bacterial infections pose significant risks due to multi-drug resistant pathogens.
- Antibiotic resistance necessitates novel therapeutic strategies beyond conventional treatments.
- Bacteriophages (viruses that infect bacteria) are emerging as a potential alternative therapy.
Purpose of the Study:
- To review the current understanding of bacteriophage therapy for neonatal infections.
- To explore the role of the early microbiota and phageome in immune development.
- To discuss the challenges and ethical considerations of phage therapy in newborns.
Main Methods:
- Systematic literature review of existing studies on phage therapy in neonates.
- Analysis of pathogen characteristics and antibiotic resistance patterns in neonatal infections.
- Examination of the interplay between microbiota, phageome, and neonatal immune system development.
Main Results:
- Phage therapy shows potential against multi-drug resistant bacteria in newborns.
- Early-life microbiota and phageome composition influence immune system maturation.
- Limited systematic data and ethical concerns currently hinder widespread clinical application.
Conclusions:
- Bacteriophage therapy presents a viable alternative for treating neonatal bacterial infections.
- Further systematic research is crucial to establish safety, efficacy, and ethical guidelines.
- Understanding the phageome's role in neonatal immunity is key for therapeutic development.
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
01:23Bacteriophages of the Human Virome
Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...
01:31Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...